Teva Pharmaceutical Industries Pre-Tax Income 2010-2024 | TEVA
Teva Pharmaceutical Industries pre-tax income for the twelve months ending June 30, 2024 was $-0.142B, a 93.62% decline year-over-year.
- Teva Pharmaceutical Industries annual pre-tax income for 2023 was $-0.624B, a 80.27% decline from 2022.
- Teva Pharmaceutical Industries annual pre-tax income for 2022 was $-3.163B, a 580.7% decline from 2021.
- Teva Pharmaceutical Industries annual pre-tax income for 2021 was $0.658B, a 114.93% decline from 2020.